Page created on November 29, 2018. Last updated on November 15, 2021 at 21:48
Acute coronary syndrome (ACS) is an umbrella term for acute presentations of coronary artery disease or ischaemic heart disease. There are three types, each of which with differing underlying pathophysiology:
- Non-ST elevation coronary syndrome (NSTE-ACS)
- Unstable angina (UA)/unstable angina pectoris (UAP)
- Non-ST elevation myocardial infarction (NSTEMI)
- ST elevation myocardial infarction (STEMI)
Acute myocardial infarct (AMI) is a disorder which occurs when there is a lasting imbalance between perfusion and blood demand of myocardium. This imbalance is most commonly due to ischaemia, but can also occur in the context of normal perfusion but increased blood demand. AMI refers to the presence of either NSTEMI or STEMI.
AMI is a type of ischaemic heart disease, and it’s one of the acute coronary syndromes. It’s a clinical diagnosis, not a pathological one, and thus it’s defined by clinical evidence of acute myocardial injury together with clinical evidence of acute myocardial ischaemia.
Myocardial injury can be detected by elevated cardiac troponin values, while evidence of ischaemia can be detected by characteristic symptoms, characteristic ECG changes, or identification of a coronary thrombus.
The majority of myocardial infarcts are are due to coronary artery disease, where atherosclerotic plaques form in the coronary arteries. When one such plaque ruptures the inside of the plaque is exposed to the blood. This is a thrombogenic surface, causing a thrombus to form on the plaque, totally or almost totally occluding the artery.
Some factors either increase the demand of the myocardium, or reduce the oxygen supply, which can aggravate the ischaemia:
Causes other than coronary artery disease include:
- Coronary spasm
Ischaemia must last approx. 20 – 40 minutes to cause necrosis. This is a type of anaemic infarct. However, because AMI is a clinical diagnosis rather than a pathological one, and because of the fact that the symptoms and clinical signs of AMI appear later than the pathological changes, we can say that the acute myocardial infarction itself doesn’t occur until the ischaemia has lasted at least 2 – 4 hours. This means that by the time a person develops symptoms of AMI their myocardium has been ischaemic for 2 – 4 hours already.
Necrosis always begins in the subendocardial myocardium and extends towards the epicardium, potentially becoming transmural if the ischaemia is severe enough. This is because the arteries lie on the epicardium, so the subendocardial myocardium is the least perfused region.
There are two types of myocardial infarction. If the coronary occlusion is complete the necrosis will be transmural, in which case it’s a type of transmural infarct. Transmural infarcts cause ST-segment elevated myocardial infarction (STEMI), where elevation of the ST-segments can be seen on ECG.
If the coronary occlusion is not complete but still severe enough to cause necrosis the necrosis will only be subendocardial. Subendocardial infarcts cause non-ST-segment elevated myocardial infarction (NSTEMI), where elevation of ST-segments is not present on the ECG. However, other ECG signs of ischaemia can be present.
Phases of myocardial infarct
The phases of myocardial infarct are best summed up in a table.
|Phase||Time-frame||Macroscopical characteristics||Microscopical characteristics||Potential complications|
|Hyperacute phase||0 – 12 hours||Only visible with diaphorase reaction||Oedema, haemorrhage||Acute left ventricular failure if 80% of myocardium is affected. Lethal arrhythmias, like ventricular fibrillation.|
|Acute phase||1 – 2 days||Yellowish, greyish. Clay-like||Signs of necrosis (no nuclei, eosinophilia)|
|Recent phase||Day 2 – week 1||Same as above, but with reddish demarcation zone||Neutrophil and macrophage infiltration.||Rupture of infarct, can cause pericardial tamponade. Rupture of papillary muscle causes acute mitral valve insufficiency. Fibrinous pericarditis.|
|Chronic (subacute) phase||Months, years||Scar tissue||Fibroblast involvement||Aneurysm of the scar tissue. Thrombosis inside aneurysm, potential embolization.
Chronic ischaemic heart disease.
The complications of acute myocardial infarct can be divided into an early group and late group.
- Early (within 48 hours)
- Sudden cardiac death
- Acute left ventricular failure
- Cardiogenic shock
- Late (after 48 hours and long-term)
- Rupture of the myocardial wall -> Pericardial tamponade
- Rupture of papillary muscles -> Mitral regurgitation
- Aneurysm of the myocardium
- Thrombosis and embolism
- Chronic ischaemic heart disease -> Heart failure
Diagnosis and treatment
As stated earlier, diagnosis is based on clinical evidence of myocardial injury and myocardial ischaemia. In practice, diagnosis is based on three factors:
- ECG changes
- ST elevation/depression
- Pathological Q waves
- Abnormal T-waves
- New-onset bundle branch blocks
- Characteristic chest pain
- A rise and/or fall in troponin levels in blood
Treatment is based on trying to restore circulation as soon as possible; the earlier reperfusion the better. For this we can use:
- Inserting an inflatable balloon that dilates the occluded artery, done in percutaneous transluminal coronary angioplasty (PTCA, also called PCI)
- Taking the great saphenous vein or internal mammary artery and connecting it to the coronaries and aorta, called coronary bypass surgery.
- Thrombolytic drugs like streptokinase or tPA to break down the thrombus
The goal of treatment in acute myocardial infarction is to salvage as much of the myocardium as possible, so tissue perfusion should be restored as early as possible. However, reperfusion can sometimes cause more bad than good when reperfusion injury occurs. This occurs by multiple factors:
Mitochondrial dysfunction occurs in the ischaemic myocardial cells. The mitochondrial membrane becomes more permeable, so osmotically activate components can enter the mitochondria and cause it to swell and burst. This releases mitochondrial contents that promote apoptosis.
During ischaemia will the intracellular calcium levels increase. After reperfusion myofibrils will contract uncontrollably, which can cause cytoskeletal damage and cell death.
During reperfusion will the ischaemic cells regain oxygen supply, but they’re so damaged that they use the oxygen to produce reactive oxygen species, which damages the cell membrane.
Leukocyte aggregation can occur during reperfusion, which can occlude the microvasculature and lead to the “no-flow” phenomenon. Platelet and complement activation also contribute to this phenomenon by damaging the endothelium.
Reperfusion arrhythmia is a potential complication of reperfusion, for unknown reasons. Reperfusion could induce dangerous arrhythmias like ventricular tachycardia and ventricular fibrillation.
Myocardial stunning is a phenomenon that may occur in myocardial cells that were ischaemic but reperfused before the ischaemia could irreversible damage the cell. In this postischaemic period the affected myocardium will be in a non-contractile state.
51. Angina pectoris, chronic ischemic heart disease, sudden cardiac death
53. Pathology of the valvular disorders (inflammatory and degenerative ones)
Theoretical exam topics